Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tadanori Morikawa
Observed names:
T Morikawa,
T. MORIKAWA,
T. Morikawa,
TADANORI MORIKAWA,
Tadanori MORIKAWA,
Tadanorl MORIKAWA
show all 6
Institution:
Fuji Chemical Industries (Japan)
Observed institutions:
Tokyo Medical and Dental University,
Juntendo University,
Fuji Chemical Industries (Japan),
Peptide Institute (Japan),
Protein Research Foundation,
University of Toyama,
Institute for Protein Research, The University of Osaka,
The University of Osaka
show all 8
OpenAlex ID:
A5109136655
Synthesis of Eel-Calcitonin and [Asu1,7]-Eel-Calcitonin: Contribution of the disulfide bond to the hormonal activity
1976
·
T. Morikawa
, E. Munekata
, et al.
·
Cellular and Molecular Life Sciences
·
95
Strategy for the synthesis of large peptides: An application to the total synthesis of human parathyroid hormone [hPTH(1–84)]
1981
·
T. Kimura
, M. Takai
, et al.
·
Biopolymers
·
86
Inhibition of Matrix Metalloproteinases by Peptidyl Hydroxamic Acids
1994
·
S. Odake
, Y. Morita
, et al.
·
Biochemical and Biophysical Research Communications
·
71
Inhibition of Helicobacter pylori Urease Activity by Hydroxamic Acid Derivatives.
1994
·
Shinjiro ODAKE
, Tadanori MORIKAWA
, et al.
·
Biological and Pharmaceutical Bulletin
·
67
PDF
Partial purification of a procollagen C-proteinase. Inhibition by synthetic peptides and sequential cleavage of type I procollagen
1982
·
Francois K. Njieha
, Tadanori Morikawa
, et al.
·
Biochemistry
·
63
Highly water-soluble matrix metalloproteinases inhibitors and their effects in a rat adjuvant-induced arthritis model
2002
·
Tetsunori Fujisawa
, Katsuhiro Igeta
, et al.
·
Bioorganic & Medicinal Chemistry
·
62
Synthesis and Structure−Activity Relationships of an Orally Available and Long-Acting Analgesic Peptide, N α -Amidino-Tyr- d -Arg-Phe-MeβAla-OH (ADAMB)
2002
·
Tadashi Ogawa
, Tetsuhisa Miyamae
, et al.
·
Journal of Medicinal Chemistry
·
35
Inhibitors of procollagen N-protease. Synthetic peptides with sequences similar to the cleavage site in the pro.alpha.1 (I) chain
1980
·
Tadanori Morikawa
, Leena Tuderman
, et al.
·
Biochemistry
·
34
A novel type of arylsulfotransferase
1987
·
Kyoichi Kobashi
, Dong-Hyun Kim
, et al.
·
Journal of Protein Chemistry
·
29
Inhibition of Urease Activity by Dipeptidyl Hydroxamic Acids.
1992
·
Shinjiro ODAKE
, Kazuaki NAKAHASHI
, et al.
·
Chemical and Pharmaceutical Bulletin
·
28
PDF
Synthesis of a biologically active analog of deamino-8-arginine-vasopressin which does not contain a disulphide bond
1969
·
S. Hase
, T. Morikawa
, et al.
·
Cellular and Molecular Life Sciences
·
26
Synthesis and Antinociceptive Activity of Orally Active Opioid Peptides: Improvement of Oral Bioavailability by Esterification
2003
·
Tadashi Ogawa
, Mamoru Araki
, et al.
·
Chemical and Pharmaceutical Bulletin
·
23
PDF
Total synthesis of human parathyroid hormone (1–84)
1982
·
Terutoshi Kimura
, Tadanori Morikawa
, et al.
·
Journal of the Chemical Society Chemical Communications
·
21
Enzymic O‐sulfation of tyrosine residues in hirudins by sulfotransferase from Eubacterium A‐44
1994
·
Ryo MURAMATSU
, Eriko NUKUI
, et al.
·
European Journal of Biochemistry
·
15
Reducing Effect of Matrix Metalloproteinase Inhibitors on Serum Triacylglycerol in Streptozotocin-Induced Diabetic Rats and Zucker fa/fa Rats
2007
·
Tadanori Morikawa
, Tomoaki Toyama
, et al.
·
Biological and Pharmaceutical Bulletin
·
14
PDF
Design and Synthesis of Sulfur Based Inhibitors of Matrix Metalloproteinase-1.
2002
·
Tetsunori Fujisawa
, Shinjiro Odake
, et al.
·
Chemical and Pharmaceutical Bulletin
·
13
PDF
Inhibition of corneal ulceration by tetrapeptidyl hydroxamic acid.
1995
·
K Kigasawa
, H Murata
, et al.
·
PubMed
·
12
Structure‐activity studies on C‐terminal hirudin peptides containing sulfated tyrosine residues
1996
·
RYO MURAMATSU
, YASUHIKO KOMATSU
, et al.
·
International journal of peptide & protein research
·
11
Novel peptides with orally active and long-lasting antihypertensive activity
1984
·
Tadanori Morikawa
, Katsumi Takada
, et al.
·
Biochemical and Biophysical Research Communications
·
10
Lactam-Conformationally Restricted Analogs of N.ALPHA.-Arylsulfonyl Arginine Amide: Design, Synthesis and Inhibitory Activity toward Thrombin and Related Enzymes.
1995
·
Toru OKAYAMA
, Sumie SEKI
, et al.
·
Chemical and Pharmaceutical Bulletin
·
9
PDF
Structure–Activity Relationships (SAR) of [D-Arg2]Dermorphin(1—4) Analogues, Nα-Amidino-Tyr-D-Arg-Phe-X
2002
·
Tadashi Ogawa
, Tetsuhisa Miyamae
, et al.
·
Chemical and Pharmaceutical Bulletin
·
8
PDF
Design and Synthesis of Carboxylate Inhibitors for Matrix Metalloproteinases.
2001
·
Tetsunori FUJISAWA
, Shin-ichi KATAKURA
, et al.
·
Chemical and Pharmaceutical Bulletin
·
7
PDF
Antithrombotic Effects of Nf-6505, a Novel Anion-binding Exosite Inhibitor
1997
·
Ryo Muramatsu
, Masashi Sasaki
, et al.
·
Thrombosis Research
·
6
Synthetic Dipeptide, N-Stearoyl-D-Ser-L-Pro-OEt, Induces Release of Tissue-Type Plasminogen-Activator in Cultured Cells and in Experimental Animals.
1994
·
Toru OKAYAMA
, Masaharu NAKANO
, et al.
·
Chemical and Pharmaceutical Bulletin
·
6
PDF
Pharmacological activities of synthetic human cholecystokinin-33 of which tyroshine was sulfated by arylsulfotransferase.
1990
·
Masaki HAGIWARA
, Eiko OHUCHI
, et al.
·
Chemical and Pharmaceutical Bulletin
·
5
PDF
Show more works
View as search
Works count:
51
Citation count:
779
H-index:
14
I10-index:
19
Year
Topic
Type
